Andere Sprachen Evotec SE

Aktien

566480

DE0005664809

EVT

Biotechnologie

Realtime-Estimate Tradegate Andere Börsenplätze 17:30:01 16.06.2025			% 5 Tage	% 1. Jan.
7,218 ^EUR	-2,43 %		+0,42 %	-12,29 %

03.06.	Evotec SE genehmigt Ernennungen für den Vorstand	CI
03.06.	TAGESVORSCHAU/Dienstag, 3. Juni	DJ

Andere Sprachen

Evotec : Presence and Voting Results AGM 2025 208.83 KB	05.06.
Evotec SE: Results of the Annual General Meeting 2025	03.06.
Evotec SE Approves Board Appointments	03.06.
Evotec : response to the FDA’s “Roadmap to Reducing Animal Testing in Preclinical Safety Studies”	20.05.
Evotec : Additional Information regarding agenda item 6 (Resolution on amending the Articles of Association to renew the option of holding virtual general meetings)	16.05.
Peptone Establishes Strategic Partnership with Evotec to Selectively Target Intrinsically Disordered Proteins and Advance Small-Molecule Therapeutics at Scale	08.05.
Evotec Secures New Grant to Develop Tuberculosis Treatments	07.05.
Evotec Receives $2.5 Mln Grant For Tb Treatments	07.05.
Evotec receives $ 2.5 m grant to generate next generation tuberculosis treatments	07.05.
Evotec : Presentation (2025 05 06 EVT Q1 Analyst call final)	06.05.
Evotec SE Reports Earnings Results for the First Quarter Ended March 31, 2025	06.05.
Evotec : Interim Statement Q1 2025, PDF (Interim Statement 3M 2025 English)	06.05.
Evotec Outlook FY Revenue EUR 840-880 Million	06.05.
Evotec SE reports Q1 2025 results: Paving the way for 2025 growth in soft market environment	06.05.
Evotec SE to announce results for the first quarter 2025 on 6 May 2025	29.04.
Evotec : Articles of Association Evotec SE, PDF	25.04.
Evotec : Convening and Agenda of the Annual General Meeting	25.04.
Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212, PDF	25.04.
Evotec : Annual financial statements 2024, PDF	25.04.
Evotec : Corporate governance declaration for the 2024 financial year, PDF	25.04.
Evotec : Remuneration report 2024 on agenda item 5, PDF	25.04.
Evotec : Modified remuneration system for members of the Supervisory Board (agenda item 7), PDF	25.04.
Evotec : Explanatory notes on the resolutionless item 1, PDF	25.04.
Evotec : Explanation of shareholders' rights, PDF	25.04.
Evotec : Proxy to a third person, PDF	25.04.

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evotec SE

Aktien

566480

DE0005664809

EVT

Biotechnologie

Andere Sprachen

Filter